Baseline variable | Univariate regression | Multivariate regression using forced inclusion model | ||||
---|---|---|---|---|---|---|
OR | 95% CI | p | OR | 95% CI | p | |
Age (per year) | 1.02 | 0.94–1.11 | 0.58 | 1.05 | 0.95–1.15 | 0.33 |
Gender (male) | 2.28 | 0.54–9.67 | 0.27 | 4.22 | 0.71–25.03 | 0.11 |
Body mass index (per 1.0) | 1.06 | 0.83–1.36 | 0.66 | - | - | - |
Hemoglobin A1c (per 0.1; %) | 0.98 | 0.89–1.04 | 0.33 | - | - | - |
Fasting plasma glucose (per 1.0; mg/dl) | 0.98 | 0.94–1.01 | 0.17 | - | - | - |
Total cholesterol (per 1.0; mg/dl) | 0.99 | 0.97–1.03 | 0.96 | - | - | - |
LDL cholesterol (per 1.0; mg/dl) | 0.98 | 0.95–1.01 | 0.21 | - | - | - |
HDL cholesterol (per 1.0; mg/dl) | 1.01 | 0.96–1.06 | 0.72 | - | - | - |
Triglyceride (per 1.0; mg/dl) | 1.01 | 0.99–1.02 | 0.20 | - | - | - |
Sulfonylureas (yes) | 1.42 | 0.26–7.76 | 0.69 | - | - | - |
Metformin (yes) | 1.60 | 0.34–7.65 | 0.56 | - | - | - |
Alpha-glucosidase inhibitor (yes) | 0.54 | 0.11–2.62 | 0.45 | - | - | - |
Thiazolidinedione (yes) | 0.86 | 0.07–1.66 | 0.91 | - | - | - |
Glinide (yes) | 1.00 | 0.00–--- | 1.00 | - | - | - |
DPP4 inhibitor (yes) | 0.86 | 0.07–10.66 | 0.91 | - | - | - |
Insulin (yes) | 1.74 | 0.40–7.91 | 0.45 | - | - | - |
Ezetimibe-therapy (yes) | 4.88 | 1.01–23.57 | 0.049 | 6.42 | 1.13–36.47 | 0.036 |